Cargando…
Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial
Autores principales: | Hindricks, Gerhard, Packer, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930874/ https://www.ncbi.nlm.nih.gov/pubmed/24371081 http://dx.doi.org/10.1093/eurheartj/eht504 |
Ejemplares similares
-
Catheter ablation of atrial fibrillation: recent advances and future challenges
por: Hindricks, Gerhard, et al.
Publicado: (2022) -
Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation
por: Tachibana, Shinichi, et al.
Publicado: (2020) -
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)
por: Mont, Lluís, et al.
Publicado: (2014) -
Catheter ablation and healthcare utilization and cost among patients with paroxysmal versus persistent atrial fibrillation
por: Friedman, Daniel J., et al.
Publicado: (2020) -
Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future
por: Dilk, Patrick, et al.
Publicado: (2022)